EMEA news in brief

Published: 7-Jul-2008


The European Medicines Agency (EMEA) has released a guideline on scientific requirements for the environmental risk assessment of gene therapy medicinal products;

It has also recommended measures to manage contamination of heparin-containing medicines;

EMEA has published a guideline on manufacturing human cell-based medicinal products;

And it has released a paper on the need for revising guidance on clinical investigation of medicinal products in the treatment of lipid disorders.

You may also like